Prognostic nutritional index predicts outcomes of malignant pleural mesotheliomaYAO, Zhou-Hong; TIAN, Guang-Yan; WAN, Yun-Yan et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 12, pp 2117-2123, issn 0171-5216, 7 p.Article

Tissue and serum EGFR as prognostic factors in malignant pleural mesotheliomaGAAFAR, Rabab; BAHNASSY, Abeer; ABDELSALAM, Ibrahim et al.Lung cancer. 2010, Vol 70, Num 1, pp 43-50, issn 0169-5002, 8 p.Article

Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestosÖKTEN, Fethiye; KÖKSAL, Deniz; ÖNAL, Mine et al.Clinical imaging. 2006, Vol 30, Num 3, pp 177-180, issn 0899-7071, 4 p.Article

A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesotheliomaMELAIU, Ombretta; CRISTAUDO, Alfonso; MELISSARI, Erika et al.Mutation research. Reviews in mutation research. 2012, Vol 750, Num 2, pp 132-140, issn 1383-5742, 9 p.Article

Complete Response and Long-term Survival in Malignant Pleural Mesothelioma: Case ReportTAKANEN, Silvia; RESULI, Blerina; GRAZIANO, Vanessa et al.Anticancer research. 2012, Vol 32, Num 4, pp 1485-1487, issn 0250-7005, 3 p.Article

Localised malignant pleural mesothelioma : a separate clinical entity requiring aggressive local surgery. DiscussionNAKAS, Apostolos; MARTIN-UCAR, Antonio E; EDWARDS, John G et al.European journal of cardio-thoracic surgery. 2008, Vol 33, Num 2, pp 303-306, issn 1010-7940, 4 p.Article

Malignant pleural mesotheliomaHUGHES, Randall S.The American journal of the medical sciences. 2005, Vol 329, Num 1, pp 29-44, issn 0002-9629, 16 p.Article

Exploratory analysis of activation of PTEN―PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)CEDRES, S; MONTERO, M. A; MARTINEZ, P et al.Lung cancer. 2012, Vol 77, Num 1, pp 192-198, issn 0169-5002, 7 p.Article

An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesotheliomaPASELLO, G; CERESOLI, G. L; FAVARETTO, A et al.Cancer treatment reviews. 2013, Vol 39, Num 1, pp 10-17, issn 0305-7372, 8 p.Article

Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesotheliomaJASANI, Bharat; COLEMAN, Sharon; BUTCHART, Eric et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2399-2402, issn 0264-410X, 4 p.Conference Paper

Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?. DiscussionNAKAS, Apostolos; BLACK, Edward; ENTWISLE, James et al.European journal of cardio-thoracic surgery. 2010, Vol 37, Num 6, pp 1457-1463, issn 1010-7940, 7 p.Conference Paper

Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesotheliomaOPITZ, I; SIGRIST, B; HILLINGER, S et al.Lung cancer. 2007, Vol 56, Num 3, pp 327-336, issn 0169-5002, 10 p.Article

Chemotherapy for malignant pleural mesothelioma: past results and recent developmentsTOMEK, Sandra; MANEGOLD, Christian.Lung cancer. 2004, Vol 45, pp S103-S119, issn 0169-5002, SUP1Article

Pemetrexed therapy for malignant pleural mesotheliomaPUTO, Katarzyna; GAREY, Jody S.The Annals of pharmacotherapy. 2005, Vol 39, Num 4, pp 678-683, issn 1060-0280, 6 p.Article

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesotheliomaGHANIM, B; HODA, M. A; SAMARZIJA, M et al.British journal of cancer. 2014, Vol 110, Num 4, pp 984-990, issn 0007-0920, 7 p.Article

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impactALI, G; BOLDRINI, L; LUCCHI, M et al.British journal of cancer. 2009, Vol 101, Num 11, pp 1869-1875, issn 0007-0920, 7 p.Article

Occupational asbestos exposure : how to deal with suspected mesothelioma cases-the dutch approachBAAS, P; VAN 'T HULLENAAR, N; WAGENAAR, J et al.Annals of oncology. 2006, Vol 17, Num 5, pp 848-852, issn 0923-7534, 5 p.Article

Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter surveyZUCALI, P. A; SIMONELLI, M; LORENZI, E et al.Lung cancer. 2012, Vol 75, Num 3, pp 360-367, issn 0169-5002, 8 p.Article

Bioluminescence imaging for in vivo monitoring of local recur- rence mesothelioma modelSHI, Yandong; HOLLENSTEIN, Andreas; FELLEY-BOSCO, Emanuela et al.Lung cancer. 2011, Vol 71, Num 3, pp 370-371, issn 0169-5002, 2 p.Article

How successful is lung-preserving radical surgery in the mesothelioma and radical surgery-trial environment? A case-controlled analysisSHAHIN, Yousef; WELLHAM, James; JAPPIE, Roxaan et al.European journal of cardio-thoracic surgery. 2011, Vol 39, Num 3, pp 360-363, issn 1010-7940, 4 p.Article

Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesotheliomaAMATORI, S; BAGALONI, I; VITI, D et al.Lung cancer. 2011, Vol 71, Num 1, pp 113-117, issn 0169-5002, 5 p.Article

Biology and management of malignant pleural mesotheliomaZUCALI, Paolo A; GIACCONE, Giuseppe.European journal of cancer (1990). 2006, Vol 42, Num 16, pp 2706-2714, issn 0959-8049, 9 p.Article

Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesotheliomaAL-TAEI, Saly; SALIMU, Josephine; LESTER, Jason F et al.Lung cancer. 2012, Vol 77, Num 2, pp 312-318, issn 0169-5002, 7 p.Article

Malignant pleural mesothelioma with osteosarcomatous differentiation: characteristic bone scintigraphy findings associated with enhanced tumorous osteogenesisNAKAO, Masayuki; HISHIDA, Tomoyuki; ISHII, Genichiro et al.European journal of cardio-thoracic surgery. 2011, Vol 39, Num 3, issn 1010-7940, p. 421Article

The role of PET in the surgical management of malignant pleural mesotheliomaFLORES, Raja M.Lung cancer. 2005, Vol 49, pp S27-S32, issn 0169-5002, SUP1Conference Paper